Innovate UK awards Stablepharma a second grant to advance fridge-free vaccines

Wealth Briefing reports on new Advisory Board Members Joining Stablepharma Ltd

Stablepharma sign a second exclusive supply agreement to develop a fridge-free Tetanus vaccine

Lorena Carmona Rodriquez as Senior Scientist to specifically progress mRNA-LNP programme.

Martin Powell RIP 1956 – 2023

Richard Amaee joins the team to progress development of fridge-free Tetanus diphtheria vaccine (SPVX02)

Professor Saul Faust, Advisory Board Member of Stablepharma, receives OBE at Buckingham Palace

Mergermarket Interview with Stablepharma CEO on future IPO and Series B raise

Stablepharma closed Series A funding round of $6.4m to progress fridge-free vaccines and mRNA/LNP stabilisation technologies

Johnny Sutton joins the Stablepharma Ltd Board of Directors

Stablepharma sign exclusive supply agreement to produce the world’s first fridge-free Tetanus diphtheria vaccine

New Data demonstrates StablevaX™-Td Vaccine Stable after 12 months at +45°C